Ranked #1
Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer
Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer
Dr Chowdhury talks to ecancertv at ASCO 2015 about the results of the TERRAIN study which looked at the use of 160 mg of... Read more
8 Aug 2017
•
7mins
Ranked #2
Non-randomised clinical trial aims to describe the safety and efficacy of commercially available, targeted anticancer drugs
Non-randomised clinical trial aims to describe the safety and efficacy of commercially available, targeted anticancer drugs
Dr Schilsky presents, at a press conference at ASCO 2015, the Targeted Agent and Profiling Utilization Registry (TAPUR).... Read more
8 Aug 2017
•
13mins
Ranked #3
Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma
Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma
Dr Larkin talks to ecancertv at ASCO 2015 about the results of a randomised phase II trial of kinase inhibitor lenvatini... Read more
8 Aug 2017
•
4mins
Ranked #4
Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma
Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma
Prof Wu talks to ecancertv at ASCO 2015 about EGFR inhibition in lung cancer.
8 Aug 2017
•
4mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ranked #5
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer
Dr Harrington talks to ecancertv at ASCO 2015 about a phase III randomised trial of pembrolizumab (MK-3475) versus stand... Read more
8 Aug 2017
•
5mins
Ranked #6
Advanced DNA sequencing test used to match rare cancers
Advanced DNA sequencing test used to match rare cancers
Dr Doroshow (National Cancer Institute, Bethesda, USA), Dr Flaherty (Massachusetts General Hospital, Boston, USA) and Dr... Read more
8 Aug 2017
•
16mins
Ranked #7
Round-up of the latest research on lung cancer
Round-up of the latest research on lung cancer
Dr Spicer talks to ecancertv at ASCO 2015, about the progress of recent drug development in lung cancer treatments.
8 Aug 2017
•
9mins
Ranked #8
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial
Adjuvant denosumab may preserve bone health in postmenopausal breast cancer patients: results of the ABCSG-18 trial
Prof Gnant talks to ecancertv at ASCO 2015 about the use of adjuvant denosumab to reduce bone problems in postmenopausal... Read more
8 Aug 2017
•
5mins
Ranked #9
Medically under-represented populations: Refining the calculation of accrual targets
Medically under-represented populations: Refining the calculation of accrual targets
Dr Comis talks to ecancertv at ASCO 2015 about a National Cancer Institute (NCI) sponsored cancer clinical trial for und... Read more
8 Aug 2017
•
4mins
Ranked #10
Screening to identify unsuitable candidates for ipilimumab in advanced melanoma
Screening to identify unsuitable candidates for ipilimumab in advanced melanoma
Dr Francesco talks to ecancertv at ASCO 2015 about the data from a study of 720 patient metastatic melanoma patients usi... Read more
8 Aug 2017
•
5mins
